Dr Daniel Hesselson

Dr Daniel Hesselson is an internationally trained research leader in regenerative medicine, focusing on cells and organs affected by heart disease, diabetes, and Parkinson’s disease. His work uses insights from the study of basic regenerative processes to identify novel therapeutic targets for these devastating diseases.

His work with zebrafish, which started at UCSF and was expanded at the Garvan Institute, made significant contributions to our understanding of the molecular mechanisms of regeneration in this highly regenerative model system. At Centenary, he is focused on exploiting these breakthroughs in basic science to develop new therapeutic strategies using the power of Directed Evolution to generate potent and highly specific biologic drugs.